ABSTRACT Syntaxin‐binding protein 1 (STXBP1) mutations lead to severe epilepsy, intellectual disability, developmental delay, and movement disorder. Effective treatments for these conditions do not exist. Recent studies in Munc18‐1 (STXBP1) C. elegans models demonstrate that 4‐phenylbutyrate (4‐PBA) or related pharmacological chaperones stabilize ...
Aline Frick +2 more
wiley +1 more source
Pediatric acute respiratory distress syndrome in children with type I - spinal muscular atrophy: a 12-year case series. [PDF]
Piastra M +20 more
europepmc +1 more source
The graphic provides an overview of the emerging field of high‐surface area vertically aligned nanopillar electrodes for electrophysiological measurements. It depicts various types of electrodes; materials, and the methods used for fabrication of vertically aligned nanopillar electrodes.
Mohammad Alzahrani +4 more
wiley +1 more source
Single-dose GC101 gene therapy for spinal muscular atrophy types II and III: an open-label single-arm study. [PDF]
Ma XW +25 more
europepmc +1 more source
Milestone discoveries of autosomal recessive childhood proximal spinal muscular atrophies
Hassan, Heba Fathy Ahmed
core
Guidelines for Essential Trauma Care: Second Edition (2026)
Injury is a major cause of death and disability globally, with the highest burden in low‐ and middle‐income countries (LMICs). Strengthening the organization and planning for trauma care (care of the injured) can improve care and lower mortality. In 2004, the International Association for Trauma Surgery and Intensive Care (IATSIC) and the World Health ...
Charles Mock +41 more
wiley +1 more source
A contemporary analysis of the Australian clinical and genetic landscape of spinal muscular atrophy: a registry based study. [PDF]
Balaji L +15 more
europepmc +1 more source
Abstract Aim To compare and examine relationships between participation, environmental factors, and quality of life (QoL) in children with cerebral palsy and physical disability (CP/PD) and typically developing children. Method Participants were 59 children (6–12 years; 31 females): 30 with CP/PD (mean age 8 years 7 months, standard deviation 1 year 6 ...
Nava Gelkop, Batya Engel‐Yeger
wiley +1 more source
Cerebrospinal fluid metabolomics reveals predictive biomarkers of nusinersen therapy efficacy in type II and type III spinal muscular atrophy patients. [PDF]
Li D +8 more
europepmc +1 more source
A perioperative nursing care protocol for patients with spinal muscular atrophy (SMA) type II or type III undergoing spinal surgery: a 4-year experience in 24 patients. [PDF]
Li G +5 more
europepmc +1 more source

